Dry Powder Inhalers (DPI)

Abstract Purpose To overcome the strong inter-particulate interactions between the drug and carrier in dry powder inhalers (DPIs), an amorphous...

Abstract Inhaled protein therapeutics offer a direct route to the lung and hold strong promise for improving respiratory disease treatment....

Abstract In this paper, the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS), discusses the current regulatory landscape associated...

Abstract This research evaluated the viability of powder discharge-based KinetiSol (pKSD) as a rapid, solvent-free particle engineering technology for producing...

From Milk to Medicine: 100 Years of Pharmaceutical Lactose continuous improvement For more than a century, lactose has quietly shaped...

Abstract The therapeutic landscape for biologics is rapidly transitioning from intravenous (IV) to subcutaneous (SC) administration, offering significant benefits in...

Abstract Background/Objectives: Cannabidiol (CBD) has emerged as a potential therapeutic agent for respiratory disorders, including asthma and chronic obstructive pulmonary...

Abstract Background/Objectives: This study aims to investigate the underexplored impact of cap- sule type on the performances of capsule-based dry...

Abstract Background/Objectives: Accurate determination of active pharmaceutical ingredient (API) particle size within dry powder inhaler (DPI) formulations is essential for ensuring...

Abstract Background/Objectives: The development of dry powder formulations for pulmonary delivery of therapeutic antibodies requires careful stabilization strategies to preserve...